Skip to main content

Advertisement

Log in

Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The purpose of this article was to describe the serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae strains isolated from adults and children with invasive disease (IPD) or acute otitis media (AOM) before introduction of the 13-valent pneumococcal vaccine. During 2009, 494 strains of S. pneumoniae isolated were collected. Complete serotyping by latex antisera and molecular methods was performed. The most frequent serotypes isolated from children with IPD were 1 (26.2%), 19A (25%) and 7F (14.3%). Serotype 19A was predominant (42.1%) in children ≤ 2 years, whereas serotype 1 was predominant (63.3%) after the age of 5. Serotype 19A was the most frequently isolated serotype from AOM (62.3%). In adults, serotypes responsible for IPD were 7F (19.4%), 19A (13.7%), 1 (8.4%) and 3 (7.5%). The serotype 19A was predominant in adults older than 65 years (19.1%). The emergence of serotype 12F was observed in adults. Between 2007 and 2009, the introduction of PCV-7 has resulted in a significant decrease of IPD caused by serotypes included in the vaccine, in children as well as in adults, confirming the herd effect. Serotype coverage of PCV-13 was 70% and 80.9% for adult and children’s IPD, respectively. PCV-13 will be more efficient in preventing invasive diseases among children and adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348(18):1737–1746

    Article  PubMed  Google Scholar 

  2. Lepoutre A, Varon E, Georges S, Gutmann L, Levy-Bruhl D (2008) Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001–2006. Euro Surveill 13(35)

  3. Agam Y, Hyun JS, Danker JF, Zhou F, Kahana MJ, Sekuler R (2009) Early neural signatures of visual short-term memory. Neuroimage 44(2):531–536

    Article  PubMed  Google Scholar 

  4. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG (2005) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294(16):2043–2051

    Article  PubMed  CAS  Google Scholar 

  5. Black S, Shinefield H, Baxter R, Austrian R, Elvin L, Hansen J, Lewis E, Fireman B (2006) Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine 24 Suppl 2:S2-79–80

    Google Scholar 

  6. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354(14):1455–1463

    Article  PubMed  CAS  Google Scholar 

  7. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A (2007) Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297(16):1784–1792

    Article  PubMed  CAS  Google Scholar 

  8. Hsu KK, Pelton SI (2003) Heptavalent pneumococcal conjugate vaccine: current and future impact. Expert Rev Vaccines 2(5):619–631

    Article  PubMed  Google Scholar 

  9. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196(9):1346–1354

    Article  PubMed  Google Scholar 

  10. Dortet L, Ploy MC, Poyart C, Raymond J (2009) Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology. Diagn Microbiol Infect Dis 65(1):49–57

    Article  PubMed  CAS  Google Scholar 

  11. Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B (2008) Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197(7):1016–1027

    Article  PubMed  Google Scholar 

  12. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B (2005) Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192(11):1988–1995

    Article  PubMed  CAS  Google Scholar 

  13. Romney MG, Hull MW, Gustafson R, Sandhu J, Champagne S, Wong T, Nematallah A, Forsting S, Daly P (2008) Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin Infect Dis 47(6):768–774

    Article  PubMed  Google Scholar 

  14. Dagan R, Gradstein S, Belmaker I, Porat N, Siton Y, Weber G, Janco J, Yagupsky P (2000) An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis 30(2):319–321

    Article  PubMed  CAS  Google Scholar 

  15. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187(9):1424–1432

    Article  PubMed  CAS  Google Scholar 

  16. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R (2006) Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 25(7):602–607

    Article  PubMed  Google Scholar 

  17. Pai R, Gertz RE, Beall B (2006) Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44(1):124–131

    Article  PubMed  CAS  Google Scholar 

  18. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW (2006) Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 193(11):1487–1494

    Article  PubMed  Google Scholar 

  19. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M (2008) Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect 14(9):835–843

    Article  PubMed  CAS  Google Scholar 

  20. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A (2006) Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368(9546):1495–1502

    Article  PubMed  CAS  Google Scholar 

  21. Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO Jr (2010) Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 125(3):429–436

    Article  PubMed  Google Scholar 

  22. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201(1):32–41

    Article  PubMed  Google Scholar 

  23. Raymond J, Le Thomas I, Moulin F, Commeau A, Gendrel D, Berche P (2000) Sequential colonization by Streptococcus pneumoniae of healthy children living in an orphanage. J Infect Dis 181(6):1983–1988

    Article  PubMed  CAS  Google Scholar 

  24. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ (2008) Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 14(2):275–281

    Article  PubMed  CAS  Google Scholar 

  25. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW (2009) Changing epidemiology of invasive pneumococcal disease in Canada, 1998–2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 49(2):205–212

    Article  PubMed  Google Scholar 

  26. Hoge CW, Reichler MR, Dominguez EA, Bremer JC, Mastro TD, Hendricks KA, Musher DM, Elliott JA, Facklam RR, Breiman RF (1994) An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 331(10):643–648

    Article  PubMed  CAS  Google Scholar 

  27. Hausdorff WP (2007) The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine 25(13):2406–2412

    Article  PubMed  Google Scholar 

  28. Gray BM, Converse GM 3rd, Dillon HC Jr (1980) Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 142(6):923–933

    Article  PubMed  CAS  Google Scholar 

  29. Henriques-Normark B, Blomberg C, Dagerhamn J, Battig P, Normark S (2008) The rise and fall of bacterial clones: Streptococcus pneumoniae. Nat Rev Microbiol 6(11):827–837

    Article  PubMed  CAS  Google Scholar 

  30. He X, McDaniel LS (2007) The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA. FEMS Microbiol Lett 269(2):189–195

    Article  PubMed  CAS  Google Scholar 

  31. Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL (2010) Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Clin Infect Dis 50(9):1238–1246

    Article  PubMed  Google Scholar 

  32. Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ (2010) Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis 10:90

    Article  PubMed  Google Scholar 

  33. Nuorti JP, Whitney CG (2010) Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59(RR-11):1–18

    PubMed  Google Scholar 

  34. Chiba N, Morozumi M, Sunaoshi K, Takahashi S, Takano M, Komori T, Sunakawa K, Ubukata K (2010) Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect 138(1):61–68

    Article  PubMed  CAS  Google Scholar 

  35. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R (2009) Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 28(4):277–282

    Article  PubMed  Google Scholar 

  36. Guzvinec M, Tesovic G, Tambic-Andrasevic A, Zidovec-Lepej S, Vukic BT, Begovac J (2008) The epidemiology of invasive Streptococcus pneumoniae disease in Croatian children. Med Sci Monit 14(12):PH59–PH64

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to J. Raymond.

Additional information

ORP Ile de France Ouest: L. Armand-Lefevre, A. Aubry, L Berardi-Grassias, E. Bille, E. Bingen, M. Bingen, G. Blanchard, I. Casin, A. Courpon, F. Delisle-Mizon, J. Decousser, , V. Leflon-Guibout, F. Leturdu, M. Leneuveu, A. Mbadi, D. Moissenet, L. Raskine, F. Richardin, V. Sivadon-Tardy, C. Souffi, J. Tankovic

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grall, N., Hurmic, O., Al Nakib, M. et al. Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine. Eur J Clin Microbiol Infect Dis 30, 1511–1519 (2011). https://doi.org/10.1007/s10096-011-1251-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1251-9

Keywords

Navigation